Adenocarcinoma: all 1,996 studies
Page 11 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Prediction of Lymph Node Invasion for Prostate AdenocarcinomaStatus unknownNCT04909957
- Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate AdenocarcinomaActive, not recruitingNCT04909294Not applicable
- Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma PatientsTerminatedNCT04894123Phase 2
- Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung AdenocarcinomaCompletedNCT04893200
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJCStatus unknownNCT04890392Phase 2
- No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal CancerCompletedNCT04864067Phase 2
- Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the StomachWithdrawnNCT04863430Phase 2
- Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China ExtensionWithdrawnNCT04859582Phase 3
- To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerTerminatedNCT04843319Phase 1/2
- ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological FeaturesStatus unknownNCT04825691
- Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived TumoroidsWithdrawnNCT04821219Not applicable
- Long-term Heart-specific Mortality in the Presence of Competing Risks Among Patients With Non-metastatic Gastric Adenocarcinoma Undergoing Resection and ChemotherapyCompletedNCT04820569
- Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's EsophagusStatus unknownNCT04818476
- Role of Neoadjuvent Radiotherapy in Locally Advanced Cancer RectumStatus unknownNCT04814784
- Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ AdenocarcinomaStatus unknownNCT04813523Phase 2
- Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic AdenocarcinomaStatus unknownNCT04812808Not applicable
- Outcome of Radiation Therapy in Operated Gastric CancerStatus unknownNCT04810663
- iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04808791Phase 2
- Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection RateCompletedNCT04802993
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- Effects of Different Methods of PDAC Specimen Acquisition on Primary Cell Culture and ApplicationStatus unknownNCT04797676
- A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDACStatus unknownNCT04794140Not applicable
- Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)Active, not recruitingNCT04793932Phase 3
- Neratinib in Patients With Metastatic Castration-Resistant Prostate CancerWithdrawnNCT04781374Phase 2
- Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade LymphomasStatus unknownNCT04773769Not applicable
- Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)CompletedNCT04769414Phase 2
- Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid TumorsStatus unknownNCT04764084Phase 1
- The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on SurvivalStatus unknownNCT04761640
- Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA TrialWithdrawnNCT04756505Phase 1
- Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)CompletedNCT04739202Phase 2
- Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort StudyStatus unknownNCT04737551
- A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDACCompletedNCT04726956
- Mechanisms of Fate Evolution of Colorectal Adenocarcinoma MetastasisStatus unknownNCT04714814
- Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Active, not recruitingNCT04704934Phase 3
- Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)Status unknownNCT04699071Phase 2
- Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched AnalysisStatus unknownNCT04692935
- Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial)Active, not recruitingNCT04692740Phase 2
- A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsTerminatedNCT04682431Phase 1
- A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)TerminatedNCT04675983Phase 3
- Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric CancerStatus unknownNCT04675866Not applicable
- Urokinase-type Plasminogen Activator Receptor and Gastroesophageal CancerCompletedNCT04669951Not applicable
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
- Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic AdenocarcinomaCompletedNCT04662112Phase 1/2
- As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to BiomarkersStatus unknownNCT04656002Phase 2
- Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.Status unknownNCT04652206Phase 1/2
- A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate CancerActive, not recruitingNCT04644770Phase 1
- Nitrates and IL-8 in Barrett's EsophagusTerminatedNCT04642690
- The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the LungCompletedNCT04634630
- Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.WithdrawnNCT04632199Phase 1
- Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaStatus unknownNCT04631757Phase 2
- Study Evaluating the Ketogenic Diet in Patients with Metastatic Pancreatic CancerCompletedNCT04631445Not applicable
- Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic CancerActive, not recruitingNCT04627246Phase 1
- Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT04609176Phase 2
- Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PACActive, not recruitingNCT04605913Phase 1/2
- Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
- NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal AdenocarcinomaTerminatedNCT04594811Phase 1
- 18F-FDG and 68Ga-FAPI PET/CT in Lung AdenocarcinomaCompletedNCT04588064Not applicable
- Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate AdenocarcinomaStatus unknownNCT04586543Phase 2
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionActive, not recruitingNCT04581473Phase 1/2
- Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerStatus unknownNCT04572542Phase 1/2
- Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line TherapyStatus unknownNCT04555304Phase 2
- Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary NodulesStatus unknownNCT04554875
- Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab TherapyActive, not recruitingNCT04554771Phase 2
- A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesCompletedNCT04544748Phase 1
- Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaActive, not recruitingNCT04543071Phase 2
- Integrative Proteomic Characterization of Pancreatic Ductal AdenocarcinomaStatus unknownNCT04525209
- Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal JunctionCompletedNCT04517747Not applicable
- Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 TrialCompletedNCT04510064Phase 2
- Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal CancerStatus unknownNCT04503967Phase 2
- Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital CenterCompletedNCT04493827
- Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA)CompletedNCT04483726Not applicable
- Assessment of What Patients and Healthcare Providers ValueCompletedNCT04483349
- Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.Status unknownNCT04483219Phase 2
- TCM in the Treatment of Lung AdenocarcinomaStatus unknownNCT04482829Not applicable
- Neoadjuvant Therapy in Biliary AdenocarcinomaWithdrawnNCT04480190Phase 1
- Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT04459078Phase 2
- Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyCompletedNCT04449679Not applicable
- A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)Status unknownNCT04446091Phase 1/2
- FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)Status unknownNCT04442984Phase 2
- A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.Status unknownNCT04435652Phase 2/3
- Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)Status unknownNCT04435067
- The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal AdenocarcinomaStatus unknownNCT04430127
- Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)Active, not recruitingNCT04423731
- A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEGStatus unknownNCT04423354Not applicable
- Neoadjuvant Therapy for Localized Rectal AdenocarcinomaWithdrawnNCT04418895Phase 2
- Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic CancerCompletedNCT04406571
- Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid TumorsCompletedNCT04400383Phase 1
- Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24)Status unknownNCT04396093
- A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04385550Phase 3
- A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerStatus unknownNCT04380103Phase 1/2
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Active, not recruitingNCT04379596Phase 2
- Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion VariantsCompletedNCT04370860
- Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT04365049
- Audit of Surgery for Colorectal CancerCompletedNCT04349384
- PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric AdenocarcinomaStatus unknownNCT04341857Phase 2
- Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof MutationWithdrawnNCT04315155Phase 1
- Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung AdenocarcinomaCompletedNCT04310943Phase 2
- EUS-RFA for Unresectable Pancreatic CancerCompletedNCT04310111Not applicable
- A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGCCompletedNCT04309578Phase 2